(Q45038526)

8 December 2017

title

Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer (English)

1 reference

8 December 2017

1 reference

5

1 reference

8 December 2017

10

1 reference

8 December 2017

Markus Schwaiger

12

0 references

Ernst J. Rummeny

11

object named as

Ernst J Rummeny

1 reference

8 December 2017

1

Michael Souvatzoglou

1 reference

8 December 2017

9

Sibylle Ziegler

1 reference

8 December 2017

Matthias Eiber

2

1 reference

8 December 2017

Toshiki Takei

3

1 reference

8 December 2017

Sebastian Fürst

4

1 reference

8 December 2017

Florian Gaertner

6

1 reference

8 December 2017

Hans Geinitz

7

1 reference

8 December 2017

Alexander Drzezga

8

1 reference

8 December 2017

Ambros J Beer

13

1 reference

8 December 2017

publication date

2 July 2013

1 reference

8 December 2017

number of pages

14

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

8 December 2017

volume

40

1 reference

8 December 2017

issue

10

1 reference

8 December 2017

page(s)

1486-1499

1 reference

Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Initial experience with FDG-PET/CT in the evaluation of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

FDG-PET/CT in re-staging of patients with lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Imaging prostate cancer: a multidisciplinary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Radionuclide and hybrid imaging of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Combined PET/MRI: a new dimension in whole-body oncology imaging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

An integrated MR/PET system: prospective applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

PET-CT image co-registration in the thorax: influence of respiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Positron emission tomography for prostate, bladder, and renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

11C-choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

[(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2467-Y

18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

21 January 2018

1 reference

12 December 2020

Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

1 reference

12 December 2020

Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.

1 reference

12 December 2020

The value of dual time point 11C-choline PET-CT in differentiating malignant from benign lesion of mediastinum

1 reference

12 December 2020

PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.

1 reference

12 December 2020

Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.

1 reference

12 December 2020

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.

1 reference

12 December 2020

Attenuation correction for a combined 3D PET/CT scanner

1 reference

12 December 2020

Imaging prostate cancer with 11C-choline PET/CT.

1 reference

12 December 2020

Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.

1 reference

12 December 2020

Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?

1 reference

12 December 2020

10.1007/S00259-013-2467-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1005017514

0 references

1 reference